Av Test Report

0 views
Skip to first unread message

Karmen Mcarthun

unread,
Jul 31, 2024, 7:02:49 AM7/31/24
to ourllorverpa

Yes, of course, I will be happy to share the file, if you tell me how it can be attached to the message here or what e-mail to send it for analysis?
Placing +10 thousand lines of the source file of the report in this message would be a very stupid step, I suppose.

Hi,
I am writing unit test using google test and generated xml file using mytest --gtest_output=xml:output.xml.
Now i want to load gtest generated xml report to sonarqube which is integrated with jenkins. I am facing issue in loading xml report and to display unit test results in dashboard.
I have used following sonar properties in groovy file
-Dsonar.tests=src/tests
-Dsonar.testExecutionReportPaths=/bin/**/tests/UnitTestCase.xml

Hi @ganncamp, @Anitha ,
I am also facing the same issue . I am using Jest framework for unit testing.
How did u fix the issue? Please suggest me on this.TIA
below are logs and sonar.properties

I'm looking for help on reporting for an A/B test. We recently had two emails that had to go out quickly to an audience. The ask was to randomize the email so that 50% of the audience received email A and 50% of the audience received email B. With this in mind, we ran an A/B test at 100% so that the audience would be split.

These emails contained surveys that had slight variations between the two. We want to send a follow up email to those who didn't click or complete the survey. However, we want to ensure that whoever received Email/Survey A gets the follow up with survey A. Same goes for Email/Survey B.

When we try to build a smart campaign to differentiate between the two, it considers it a whole email test so I can't determine who received A vs. B. Is there a way to run a report to determine who received which test?

I used the same way as you did.. My Actual output from the VI will have more than 1000 words. but in teststand report it is printing only initial 5 -6 words. it is not printing all the words from LabVIEW VI.

Do you have some special characters after these words? I haven't tested this but things like new line, line break, line feed could stop the plugin to add the text.... (which i wouldn't expect, but other special character could result in that behavior)

A test report summary contains all the details of the testing process, what was tested, when was it tested, how it was tested, and the environments where it was tested. Compared to those created in the Waterfall versions, the test summary report in Agile development processes is less formal and more focused on the results.

The definition of a Test Summary is as simple as the name suggests. It is also known as a Test Closure Report. It provides the relevant stakeholders with a detailed account of the overall test results and defects. It aims to summarize the results of the entire testing process formally.

Test Summary Report is an important document that is prepared at the end of a Testing project, or rather after the Testing cycle has been completed. The prime objective of this document is to explain the details of the Testing activities performed for the Project, to the respective stakeholders like Senior Management, Clients, etc. It also portrays the overall quality level of the application.

While the Daily Status Reports only deliver the daily test status and results to the stakeholders, Test Summary Report on the other hand provides a consolidated report on the overall testing activities performed in the cycle.

A test summary report is ideally created at the end of testing cycles, so it can also include details about regression tests. However, there should be enough time after submitting the report and before the product is shipped to the customers. The intention here is to help the client and the stakeholders with the information on the overall health of the testing cycle and the application being tested so that any corrective action can be taken if necessary.

An informative test summary report should be concise and relevant. Several examples of Test Summary Report templates are available online, but all of them might not be applicable in your case. Therefore, it is vital to customize our report according to the nature of our test project after doing a proper analysis.

In this step, we should capture the testing scope of the application, which means the areas/modules that are In Scope, Out of Scope and also the areas that were not tested due to any constraints or dependencies.

In this step, capture the various Testing types performed for the product. This ensures that the application is being tested properly. We can also capture the details if multiple rounds of testing are done. For example,

Smoke or Sanity tests were performed whenever a new build was deployed into the test environment to ensure that the major functionalities of the application are working fine. If the test results were up to mark, the build was accepted and promoted to other test environments for the QA team to start testing.

In this step, capture the details about the Test Environment in which the testing activities mainly were carried out, Application URL, Database version, etc. Also, capture the details of any tools used for Bug Management, like JIRA or Selenium for automation.

Utilize this section to describe the critical issues faced and the solutions implemented to get past those problem areas during the testing. These learnings made will help during the next Testing phase, and hence it is important to capture the details about them.

This section captures whether the Testing team gives a Green Signal for the application to Go Live and if the Exit Criteria were fulfilled. Suppose the Exit Criteria are not fulfilled completely. In that case, the relevant areas of concern can be highlighted and the decision can be left further with the Senior Management and other stakeholders if the application can Go Live or not.

Once the test summary reports are designed, it is essential to share them with the stakeholders and clients and the team. With the test summary report, the team members will get an overview of the entire testing cycle which will help them in improving further. The reports can be of great help for newcomers as well.

You can leverage BrowserStack integration with Slack to share these test summary reports daily within the team in an automated way. Integrating Slack with BrowserStack can help you to debug your failed tests directly from Slack and obtain a summary of all your builds executed during the day.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Unless noted otherwise, content on this page comes from Attachment E in Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process," also referred to as the FDA's Biocompatibility Guidance on Use of ISO 10993-1.

"Whenever biocompatibility or chemical characterization testing information is included in a submission, the FDA recommends that complete test reports be provided for all tests performed unless testing is conducted under the ASCA program and it is determined that an ASCA Summary Test Report is sufficient or a declaration of conformity without supplemental information can be appropriately provided."

Note: "The ISO 10993 series of standards do not specify either a method or test outcome, because these standards are both compendia and guidance. As such, these standards allow one to select different tests and methods, and do not necessarily include acceptance criteria. Therefore, to support a declaration of conformity and for FDA to assess conformance, for any tests selected under the ISO 10993 paradigm, the rationale for the test battery selected and the criteria used to determine acceptance should be provided. It has been FDA's experience that test reports often address this, and raw data is usually not necessary. There may be other testing for which a declaration of conformity can be submitted to FDA without supplemental information."
[SOURCE: FDA's Biocompatibility Guidance on Use of ISO 10993-1]

"Test reports for GLP studies must address the reporting requirements of 21 CFR 58 and all test reports (for both GLP and non-GLP studies) should also include the sections described below. Test reports should address the reporting provisions of any referenced standards, as well as the information outlined below."

"As described in Section V.A" of the FDA's Biocompatibility Guidance on Use of ISO 10993-1, "the test report should identify the test specimen; if the test article is not the medical device in its final finished form, a justification for the test article used should be provided either in the test report or in the submission to FDA" (See Attachment F of the FDA's Biocompatibility Guidance on Use of ISO 10993-1).

Note: As discussed in ISO 10993-1, any justification should include a risk analysis, which "begins with identification and characterization of the indirect and direct tissue-contacting materials and components of the medical device. This should be done based on the final form of the medical device in its manufactured state, taking into account the presence of any manufacturing additives, processing aids or other potential contaminants such as sterilant residues."
[SOURCE: ISO 10993-1:2018, B.3.1.2; see also Attachment F of the FDA's Biocompatibility Guidance on Use of ISO 10993-1 for the Component and Device Documentation Examples Test Method]

"The test report should provide a summary of the method used. If the method used is not in a published guidance document or FDA-recognized standard, a complete description of the method should be provided. If the test method is a modified version of a method in a published guidance document or FDA-recognized standard, the test report should include an explanation of the differences and their potential impact on the interpretation of the results."

93ddb68554
Reply all
Reply to author
Forward
0 new messages